Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.
Authors:
- E SexsmithESE Sexsmith
- A GottliebAGA Gottlieb
- F P LiFLF P Li
- D MalkinDMD Malkin
Open Access
- 1 April 1995
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 95 (4) , 1606-1611
Abstract
We investigated the possibility that a proportion of children with sporadic rhabdomyosarcoma (RMS) carry constitutional mutations of the p53 tumor suppressor gene. 33 patients with sporadic RMS at two large outpatient pediatric oncology clinics submitted blood samples. Genomic DNA was extracted from peripheral blood leukocytes and PCR was used to amplify exons 2-11 of the p53 gene. Amplified genomic DNA was screened for the presence of germline p53 mutations using single-strand conformation polymorphism (SSCP) analysis. The DNA sequence of those samples that showed aberrant migration of bands on SSCP analysis was determined to identify the precise nature of the gene mutations. Patient records were reviewed to assess clinical correlates of the mutant p53 carrier state. Heterozygous constitutional mutations were detected in 3/33 patient samples screened. Two of these missense mutations are located in exon 7 and one in exon 8 of the p53 gene. The presence of mutations was not correlated with tumor histology, stage, or site. However, an association between young age at diagnosis and presence of a constitutional p53 mutation was noted: 3/13 children under the age of 3 yr at diagnosis carried mutations, whereas none of 20 children over 3 yr of age at diagnosis harbored a detectable constitutional mutation. These results in children with RMS corroborates previous findings in other clinical settings suggesting that the mutant p53 carrier state may predispose individuals to malignancy at an early age. Although this study did not assess whether the mutations were preexisting or new germline alterations, assessment of close relatives of RMS patients for cancer risk and predictive genetic testing may be indicated.Keywords
This publication has 49 references indexed in Scilit:
- Clinical Implications of the p53 Tumor-Suppressor GeneNew England Journal of Medicine, 1993
- p53 is required for radiation-induced apoptosis in mouse thymocytesNature, 1993
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Detection of Novel Germ-line p53 Mutations in Diverse-Cancer-Prone Families Identifiled by Selecting Patients With Childhood Adrencortical CarcinomaJNCI: Journal of the National Cancer Institute, 1992
- TP53 tumor suppressor gene: A model for investigating human mutagenesisGenes, Chromosomes and Cancer, 1992
- Localization of the rhabdomyosarcoma t(2;13) breakpoint on a physical map of chromosome 13Genomics, 1991
- p53 germline mutations in Li-Fraumeni syndromeThe Lancet, 1991
- p53 Mutations in Human CancersScience, 1991
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971